TUBB3locvps

locvps  时间:2021-01-03  阅读:()
TableS1:Detailedclinico-pathologicalinformationforthePUMsAbbreviations:PM=primarymanagement,LBD=largestbasaldiameter,UH=ultrasoundheight,CBI=ciliarybodyinvolvement,EOE=extraocularextension,HPF=highpowerfields,Enuc=enucleation,PBT=protonbeamRXT,LR=localresection,N=no,Y=yes,N/A=notassessed,del=deletion,amp=amplification,M3=monosomy3*=fromaSNPdataSampleIDPUMtoMUM01PUM02(MUM03)PUMtoMUM05PUM04(MUM07)PUM05(MUM08)PUMtoMUM09PUMtoMUM10PUM08(MUM11)PUMtoMUM13PUMtoMUM17PUMtoMUM18PUM18(MUM21)AgeatPM645439696448666560675467GenderMaleMaleFemaleFemaleFemaleMaleMaleFemaleFemaleMaleMaleMaleTypeofPMEnucEnucEnucEnucEnucPBTEnucLR,EnucEnucPBTPBTEnucLBD(mm)15.
516.
618.
718.
918.
78.
716.
514.
3418.
516.
215.
2UH(mm)7.
52.
48.
389.
72.
237.
64.
33.
99.
414.
1CBINNNYNNNNYNNNEOENNNNNNNNY(Episclera)NNNEpithelioidCellsYYYYYYYYYYNRYClosedLoopsYYYYNNRYYNNRNRYMitoticCount(40HPF)516286NR10204NRNR52Chr.
3status*N/AHeterozygousdeletionsandROHN/AHeterozygousdeletionsandROHHeterozygousdeletionsandROHN/AN/AHeterozygousdeletionsandROHN/AN/AN/AHeterozygousdeletionsandROHChr.
8qstatus*N/APartialampN/AAmpAmpN/AN/AAmpN/AN/AN/AAmpTableS2:Detailedclinico-pathologicalinformationfortheMUMsAbbreviations:dia=diameter,NR=notreported,N=no,Y=yes,NA=notapplicable,del=deletion,amp=amplification,D3=disomy3,M3=monosomy3,MM=metastaticmelanoma*=fromaSNPdata**=timebetweenprimarydiagnosisandlastfollow-upSampleIDMUM01MUM03MUM05MUM07MUM08MUM09MUM10MUM11MUM13MUM17MUM18MUM21TypeofSampleLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLiverresectionLaparoscopicbiopsyLaparoscopicbiopsyLiverresectionLiverresectionLiverresectionLesionsize(mm)40x35x1316x15x1415x11x1037x36x6225x20x320india11x9x104india12india5x2x135x25x23NRLiverSegmentIVaVIII,IIIVIII,V,VIINRVIINANANRV,VINRCellTypeMixedMixedMixedMixedEpithelioidEpithelioidSpindleSpindleMixedMixedSpindleNRPigmentationNYYYYNNRNYYYNRChr.
3status*HeterozygousdeletionsandROHHeterozygousdeletionsandROHHeterozygousdeletionsandROHIsodisomyHeterozygousdeletionsandROHIsodisomyIsodisomyHeterozygousdeletionsandROHM3M3D3M3Chr.
8qstatus*AmpPartialampAmpAmpAmpAmpAmpAmpAmpAmpAmpAmpDeceasedYNYYYYYYYYNYCauseofDeathMM---MMMMMMMMMMMMMMMM---MMOverallSurvivalTime(years)5.
513.
4**4.
22.
72.
94.
43.
31.
98.
11.
211.
1**4.
3TableS3:Listof193geneswithCNVsidentifiedinPUM02,PUM04,PUM05,andPUM08GeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolAARSCENPTDUS2KLHDC4MBTPS1NUTF2SLC7A6TUBB3ACDCHMP1AEDC4KLHL36MC1ROSGIN1SLC7A6OSURAHPACSF3CHTF8ENKD1LCATMIR140PABPN1LSMG1P7USP10ADAD2CIRH1AESRP2LINC00304MIR1538PARD6ASNAI3VAC14AFG3L1PCLEC18AEXOSC6LINC00311MIR1972-1PDFSNAI3-AS1VILLAGRPCLEC18CFAM157CLOC100129697MIR1972-2PDPRSNORD111VPS4AANKRD11COG4FAM65ALOC100131303MIR26A1PDXDC2PSNORD111BVPS9D1APRTCOG8FAM92BLOC100287036MIR3155APFKFB3SNORD68VPS9D1-AS1ASB13COTL1FANCALOC100289580MIR3155BPIEZO1SNTB2WFDC1ATP2C2CPNE7FBXO31LOC100505942MIR4722PLA2G15SPATA2LWWP2ATP6V0D1CRISPLD2FUKLOC100506083MIR5093PLCD1SPATA33ZC3H18BANPCTCFGALNSLOC101927817MIR5189PRDM7SPG7ZCCHC14C16orf86CTRLGAS8LOC101928682MIR6773PRMT7SPIRE2ZDHHC1C16orf95CTU2GAS8-AS1LOC101928708MIR6775PSKH1ST3GAL2ZDHHC7CA5ACYB5BGFOD2LOC101928737MLYCDPSMB10TAF1CZFPM1CALML3CYBAHAS3LOC101928880MTSS1LRANBP10TANGO6ZNF276CALML3-AS1DBNDD1HSD11B2LOC102724467MVDRBM17TCF25ZNF469CALML5DDX19AHSDL1LOC339059NECAB2RLTPRTERF2ZNF778CBFA2T3DDX19BIL15RALOC399715NET1RNF166THAP11TableS4:Listof135geneswithCNVsidentifiedinallPUM-MUMpairsGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolGeneSymbolADAM6CYP11B2HGH1LYPD2MIR6849PUF60TMED10P1ZNF7ADCK5DENND3HSF1MAF1MIR6850PYCRLTMEM249ZNF707AGO2DGAT1JRKMAFAMIR6893RECQL4TONSLARCEEF1DKIAA0125MAFA-AS1MIR7112RHPN1TOP1MTARHGAP39EPPK1KIAA1875MAPK15MIR7641-2RHPN1-AS1TRAPPC9BAI1ETV5KIFC2MFSD3MIR937RNF5P1TSNARE1BOP1EXOSC4LINC00051MIR1268AMIR939RNU6-2TSTA3BREA2FAM83HLINC01300MIR1302-7MROH1RPL8VPS28C8orf31FAM83H-AS1LOC100133669MIR4472-1MROH5SCRIBZC3H3C8orf33FBXL6LOC100287098MIR4507MROH6SCRT1ZFP41C8orf82FOXH1LOC100288181MIR4537NAPRTSCXZNF16CCDC166GLI4LOC100507316MIR4538NRBP2SHARPINZNF250CDC42P3GMLLRRC14MIR4539OPLAHSLC39A4ZNF251CHRAC1GPAA1LRRC24MIR4664PARP10SLC45A4ZNF252PCOMMD5GPIHBP1LY6DMIR661PLECSLC52A2ZNF252P-AS1CPSF1GPR20LY6EMIR6845PPP1R16ASLURP1ZNF34CYC1GPTLY6HMIR6846PSCASPATC1ZNF517CYHR1GRINALY6KMIR6847PTK2THEM6ZNF623CYP11B1GSDMDLYNX1MIR6848PTP4A3TIGD5ZNF696TableS5:DetailedresultsofSNPanalysisandIHCforallMUMsassessedSampleGeneMUM01MUM05MUM07MUM08MUM10MUM11MUM17MUM18MUM21C-MYCCNamplificationamplificationamplificationamplificationamplificationamplificationamplificationamplificationamplificationAsCNampwAIampwAIampwAIampwAIampwAIampwAIampwAIampw/oAIampwAIIHC(nuclear)moderate50%moderate70%weak5%strong80%weak20%strong95%moderate40%moderate90%strong80%IHC(score)452727467BAP1CNunchangeddeletionunchangedunchangedunchangeddeletiondeletionunchangeddeletionAsCNAllelichomozygosityLOHAllelichomozygosityAllelichomozygosityAllelichomozygosityLOHLOHunchangedLOHIHC(nuclear)negativenegativenegativenegativenegativenegativenegativepositivenegativeAbbreviations:CN=copy-numberanalysis,AsCN=allele-specificcopy-numberanalysis,IHC=immunohistochemistry,amp=amplification,LOH=lossofheterozygosity,AI=allelicimbalanceFigureS1:OverviewofchromosomaldistributionofgeneCNVsinMUMs.
Top:Amplificationswerefoundonallidentifiedchromosomes,exceptforchr.
3.
Themostcommongeneamplificationsoccurredonchr.
8,followedbychr.
20,17,and19.
Manyamplifiedgeneswereseenin50%(6/12)orlesssampleswithinthecohort.
Bottom:Deletionswerelessfrequentandmainlyoccurredonchr.
3.
However,notmorethan8/12MUMsshowedthesamegenedeletion.
FigureS2:ComparisonofCNandAsCNanlysis.
OntheleftthechromosomaldistributionfortheCNVsidentifiedwithintheMUMsaredepictedforchr.
3.
OntherightthechromosomaldistributionfortheidentifiedAsCNwithinthecohortareshownforchr.
3.
MostlyregionswithnoamplificationordeletionbyCNanalysisshowregionsofhomozygosity(ROH)inAsCNanalysis.
.
FigureS3:VennDiagrams(VD)ofdetailedanalysisofthefivePUM-MUMpairs.
TheindividualVDsforeachpair(atthetopandbottom)revealinformationregardingthecountofalteredgenesbeinguniquetoMUM(green),uniquetoPUM(red),andaresharedbetweenbothpartnersofthepair(yellow,intersect).
VDscombiningthisinformation(middle)revealthatfortheMUMsnoCNVwassharedbymorethanthreesamples,135geneswerefoundinallfivepairs,and194CNVsweredetectedinfourPUMs.

华纳云E5处理器16G内存100Mbps688元/月

近日华纳云商家正式上线了美国服务器产品,这次美国机房上线的产品包括美国云服务器、美国独立服务器、美国高防御服务器以及美国高防云服务器等产品,新产品上线华纳云推出了史上优惠力度最高的特价优惠活动,美国云服务器低至3折,1核心1G内存5Mbps带宽低至24元/月,20G ddos高防御服务器低至688元/月,年付周期再送2个月、两年送4个月、三年送6个月,终身续费同价,有需要的朋友可以关注一下。华纳云...

HostKvm($4.25/月),俄罗斯CN2带宽大升级,俄罗斯/香港高防限量5折优惠进行中

HostKvm是一家成立于2013年的国外VPS服务商,产品基于KVM架构,数据中心包括日本、新加坡、韩国、美国、俄罗斯、中国香港等多个地区机房,均为国内直连或优化线路,延迟较低,适合建站或者远程办公等。本月,商家旗下俄罗斯、新加坡、美国、香港等节点带宽进行了大幅度升级,俄罗斯机房国内电信/联通直连,CN2线路,150Mbps(原来30Mbps)带宽起,目前俄罗斯和香港高防节点5折骨折码继续优惠中...

Megalayer新加坡服务器国际带宽线路测评

前几天有关注到Megalayer云服务器提供商有打算在月底的时候新增新加坡机房,这个是继美国、中国香港、菲律宾之外的第四个机房。也有工单询问到官方,新加坡机房有包括CN2国内优化线路和国际带宽,CN2优化线路应该是和菲律宾差不多的。如果我们追求速度和稳定性的中文业务,建议还是选择CN2优化带宽的香港服务器。这里有要到Megalayer新加坡服务器国际带宽的测试服务器,E3-1230配置20M国际带...

locvps为你推荐
免费虚拟主机国内好的免费虚拟主机虚拟主机价格虚拟主机一般多少钱一年域名备案查询如何查询自己域名是否备案,怎么查询备案号?美国vps主机求介绍一款英国的VPS主机?代理主机电脑店卖组装机,怎么赚钱。海外域名求国外域名商列表域名备案域名怎么进行备案?网站空间购买国内网站空间购买哪里的比较实惠啊?虚拟主机评测网哪里有可靠的免费虚拟主机1g虚拟主机想买个1G虚拟主机,不限流量的,但不知道哪个建站网站靠谱,求推荐!
上海虚拟主机 n点虚拟主机管理系统 草根过期域名 lnmp 谷歌香港 表格样式 贵州电信宽带测速 云主机51web 轻量 howfile 什么是刀片服务器 空间论坛 柚子舍官网 hinet adroit 免费美国空间 中国电信测速网 安徽双线服务器 免费mysql数据库 华为云盘 更多